Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome

Clinical trial NCT02343133 · COMPLETED

Trial details

NCT number: NCT02343133
Sponsor: Neumedicines Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic Syndrome Due to Acute Radiation Syndrome

Start date: 2015-01-01
Primary completion: 2016-04-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.